Peter J. Kuipers - 29 Jan 2026 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Reporting relationship: Chief Financial Officer
Issuer ticker: CLOV
Reported as of: 29 Jan 2026
Net transaction value: -$362,337
SEC form: 4
Accepted by SEC: 02 Feb 2026, 16:35:11 UTC
Prior SEC filing: 31 Oct 2025
Source filing: View source filing
Reporting owner signature: Peter J. Rivas as attorney-in-fact for Peter Kuipers

Key filing fact

Peter J. Kuipers filed Form 4 for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) on 02 Feb 2026.

Key facts

This page summarizes Peter J. Kuipers's Form 4 filing for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Feb 2026, 16:35.

Change

Previous filing in this sequence was filed on 31 Oct 2025.
Current net transaction value: -$362,337.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001651691 Primary reporting owner

Kuipers Peter J.

Relationship: Chief Financial Officer
Address: C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON
Signature: Peter J. Rivas as attorney-in-fact for Peter Kuipers
Signature date: 02 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLOV transaction

Class A Common Stock

Tax liability

Transaction value: $362,337
Shares: -156,856
Change %: -2.7%
Price: $2.31
Shares after: 5,758,353
Date: 29 Jan 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 29, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on April 29, 2024. The remaining RSUs vest in equal quarterly installments, with a final vesting date on April 29, 2028, in each case subject to the continued service of the Reporting Person on such vesting date.